Ming-Mo Hou
, M.D.
Institution: Chang Gung Memorial Hospital (CGMH) at Linkou
Position: Physician
Department: Division of Hematology-Oncology, Department of Internal Medicine,
Address: No.5, Fusing St., Gueishan Township, Taoyuan County 333, Taiwan (R.O.C.)
Tel: +886-3-3281200
E-mail:
student871029@gmail.com
Focus of Interest:- Oncology
- Medicine, General & Internal
Employment Records:Resident in Department of Internal Medicine, Chang Gung Memorial Hospital
Fellow in Division of Oncology, Chang Gung Memorial Hospital
Education:Sep, 1998 ~ Jun, 2005 Medicine of Chung Shan Medical University
Selected Publications:1. Ming-Mo Hou, Xiaochun Liu, Jennifer Wheler, Aung Naing, David Hong, Diane Bodurka, Kathleen Schmeler, Apostolia Tsimberidou, Filip Janku, Ralph Zinner, Sarina Piha-Paul, Chung-Yuan Hu, Karen Lu, Razelle Kurzrock, and Siqing Fu. Outcomes of Patients with Metastatic Cervical Cancer in a Phase I Clinical Trials Program. Anticancer Research 34:xxx-xxx(2014)
2. Siqing Fu, Ming-Mo Hou, Jennifer Wheler, David Hong, Aung Naing, Apostolia Tsimberidou, Filip Janku, Ralph Zinner, Sarina Piha-Paul, Gerald Falchook, Macus Tien Kuo, Razelle Kurzrock. Exploratory study of carboplatin plus the copper-lowering agent trientine in patients with advanced malignancies. Invest New Drugs. 2013 Dec 5.PMID: 24306314
3. Ming-Mo Hou, Shiu-Feng Huang, Han-Pin Kuo, Cheng-Ta Yang, Ying-Huang Tsai, Chih-Teng Yu, Horng-Chyuan Lin, Chih-Hung Chen, Chih-Liang Wang, Fu-Tsai Chung, Jia-Juan Hsieh, Todd Hsu, Hsin-Yi Cheng, Li-Ying Ou, Hung-Ming Wang, Yung-Chang Lin, Nai-Jen Chang, John Wen-Cheng Chang. Erlotinib treatment in patients with advanced lung adenocarcinoma with CISH-positive and CISH-negative EGFR gene alterations. Anticancer research 2012, 32(3): 1107-12
4. John Wen-Cheng Chang, Nien-Chih Wei, Hung-Ju Su, Jie-Len Huang, Tse-Ching Chen, Yi-Cheng Wu, Chih-Teng Yu, Ming-Mo Hou, Chia-Hsun Hsieh, Jia-Juan Hsieh, Chiao-En Wu, Hsin-Yi Cheng, Todd Hsu, Tzu-Hao Wang. Comparision of genomic signatures of non-small cell lung cancer between two microarray plateforms. Anticancer research 2012, 32(4): 1259-65.
5. Ming-Mo Hou, John Wen-Cheng Chang, See-Tong Pang, Yang-Jen Chiang, Yung-Chi Shen, Shuen-Kuei Liao, Jia-Juan Hsieh, Kun-Yun Yeh, Nai-Jen Chang, *Cheng-Keng Chuang. Characterization of the Response of Dendritic Cells and Regulatory T Cells to Tumor Antigens in Patients with Renal Cell Carcinoma. Chang Gung Medical Journal 2010, 33(1): 25-35.
Full Publication List
Board Certification/Professional Affiliations:
Taiwan Medical Association, License: 038913 on 2005-09-14
Taiwan Society of Internal Medicine, License: 008105 on 2008-12-12
Society of Chinese Oncology, License: 99013 on 2010-11-13
Ongoing Projects:Novel Biotechnologies and Biomarkers for the Management of Non-Small Cell Lung Cancer